Company

Ginwa Enterprise

Headquarters: Xi'an, China

Employees: 676

SSE: 600080 -0.49%

Market Cap

CN¥2.83 Billion

CNY as of Jan. 1, 2026

US$403.9 Million

Market Cap History

Ginwa Enterprise Categories

China Healthcare Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Ginwa Enterprise market capitalization over time

Evolution of Ginwa Enterprise market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Ginwa Enterprise

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector:
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Detailed Description

Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells proprietary Chinese, biological, and chemical medicines in China. It offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. The company provides its products in the form of capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. is based in Xi'an, China.

Stocks & Indices

Ginwa Enterprise has the following listings and related stock indices.


Stock: SSE: 600080 wb_incandescent

Details

Headquarters:

No. 202, Keji 4th Road

High-tech Zone

Xi'an, None

China

Phone: 86 29 8220 0221

Fax: 86 29 8177 8627